Related Experiment Video
Updated: Mar 21, 2026
10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.7K
Phase I study of single-agent CC-292, a highly selective Bruton's tyrosine kinase inhibitor, in relapsed/refractory
Jennifer R Brown1, Wael A Harb2, Brian T Hill3
1Dana-Farber Cancer Institute, Boston, MA, USA jennifer_brown@dfci.harvard.edu.
Haematologica
|May 7, 2016
Abstract
No abstract available in PubMed .
Keywords:
BTK inhibitorsCC-292chronic lymphocytic leukemiarefractoryrelapsedsingle-agentsmall lymphocytic lymphomaMore Related Videos
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
22.7K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.9K
